Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 24 results:
Author Title [ Type(Desc)] Year
Filters: Author is Souverein, P. C.  [Clear All Filters]
Journal Article
E. M. van de Garde, Souverein, P. C., Hak, E., Deneer, V. H., van den Bosch, J. M., and Leufkens, H. G., Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes, J Hypertens, vol. 25, pp. 235-9, 2007.
V. Abbing-Karahagopian, Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C., Gardarsdottir, H., and De Bruin, M. L., Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
M. J. Warnier, Rutten, F. H., Souverein, P. C., de Boer, A., Hoes, A. W., and De Bruin, M. L., Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol, Pharmacoepidemiol Drug Saf, vol. 24, pp. 701-8, 2015.
A. M. van Strien, Souverein, P. C., Keijsers, C., Heerdink, E. R., Derijks, H. J., and van Marum, R. J., Association Between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults, J Clin Psychopharmacol, vol. 38, pp. 296-301, 2018.
S. H. Mahmoudpour, Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., and van der Zee, A. H. Maitlan, Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink, Br J Clin Pharmacol, vol. 82, pp. 1647-1659, 2016.
B. M. Verdel, Souverein, P. C., Egberts, A. C., and Leufkens, H. G., Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure, Ann Pharmacother, vol. 40, pp. 1040-6, 2006.
C. Huerta, Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., De Bruin, M. L., Slattery, J., de Groot, M. C., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., Garcia-Rodriguez, L. A., Johansson, S., de Vries, F., Schlienger, R. G., Reynolds, R. F., Klungel, O. H., and de Abajo, F. J., Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
B. P. Verhaegh, de Vries, F., Masclee, A. A., Keshavarzian, A., de Boer, A., Souverein, P. C., Pierik, M. J., and Jonkers, D. M., High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors, Aliment Pharmacol Ther, vol. 43, pp. 1004-13, 2016.
G. Requena, Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., Miret, M., Schneider, C., Souverein, P. C., Webb, D., Afonso, A., Boudiaf, N., Martin, E., Oliva, B., Alvarez, A., de Groot, M. C., Bate, A., Johansson, S., Schlienger, R., Reynolds, R., Klungel, O. H., and de Abajo, F. J., Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
P. C. Souverein, Webb, D. J., Petri, H., Weil, J., van Staa, T. P., and Egberts, T., Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database, Epilepsia, vol. 46, pp. 304-10, 2005.
A. G. Boef, Souverein, P. C., Vandenbroucke, J. P., A. Vlieg, vanHylckama, de Boer, A., le Cessie, S., and Dekkers, O. M., Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives, Pharmacoepidemiol Drug Saf, vol. 25, pp. 317-24, 2016.
R. G. Duijnhoven, Straus, S. M., Souverein, P. C., de Boer, A., Bosch, J. L., Hoes, A. W., and De Bruin, M. L., Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer, Cancer Causes Control, vol. 25, pp. 1577-82, 2014.
S. H. Mahmoudpour, Asselbergs, F. W., Souverein, P. C., de Boer, A., and van der Zee, A. H. Maitlan, Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study, Br J Clin Pharmacol, vol. 84, pp. 2365-2372, 2018.
K. B. Handoko, Souverein, P. C., van Staa, T. P., Meyboom, R. H., Leufkens, H. G., Egberts, T. C., and van den Bemt, P. M., Risk of aplastic anemia in patients using antiepileptic drugs, Epilepsia, vol. 47, pp. 1232-6, 2006.
D. C. Braeken, Rohde, G. G., Franssen, F. M., Driessen, J. H., van Staa, T. P., Souverein, P. C., Wouters, E. F., and de Vries, F., Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom, Int J Chron Obstruct Pulmon Dis, vol. 12, pp. 2425-2432, 2017.
B. Spaetgens, de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., and Joosten, L. A. B., Risk of infections in patients with gout: a population-based cohort study, Sci Rep, vol. 7, p. 1429, 2017.
E. M. van de Garde, Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M., and Leufkens, H. G., Statin treatment and reduced risk of pneumonia in patients with diabetes, Thorax, vol. 61, pp. 957-61, 2006.
P. C. Souverein, van Staa, T. P., Egberts, A. C., De la Rosette, J. J., Cooper, C., and Leufkens, H. G., Use of alpha-blockers and the risk of hip/femur fractures, J Intern Med, vol. 254, pp. 548-54, 2003.
P. C. Souverein, Webb, D. J., Weil, J. G., van Staa, T. P., and Egberts, A. C., Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy, Neurology, vol. 66, pp. 1318-24, 2006.
F. de Vries, Souverein, P. C., Cooper, C., Leufkens, H. G., and van Staa, T. P., Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands, Calcif Tissue Int, vol. 80, pp. 69-75, 2007.
P. C. Souverein, Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C., Leufkens, H. G., and Walker, B. R., Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, vol. 90, pp. 859-65, 2004.
A. Keyany, Nielen, J. T. H., Souverein, P. C., de Vries, F., and van den Bemt, B., Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study, Diabetes Res Clin Pract, vol. 139, pp. 100-106, 2018.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study, J Intern Med, vol. 285, pp. 205-214, 2019.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study, J Intern Med, 2018.
[Page last reviewed 4 October 2019]